2016 EHA Congress


Recent developments in the management of patients at risk of thromboembolism – from non-malignant to malignant conditions No ratings yet.

Deborah Siegal, MD, MSc, FRCPC
Clinical Scholar, Department of Medicine
Investigator, Population Health Research Institute
McMaster University
Hamilton, Ontario, Canada

Results from ENESTop: Treatment-free remission following switch to Nilotinib in patients with chronic myeloid leukemia in chronic phase No ratings yet.

Prof. Tim Hughes, MB.BS, MD, FRACP, FRCPA
Cancer Theme Leader
South Australian Health and Medical Research Institute (SAHMRI)
Beat Cancer Professor
University of Adelaide
Adelaide, South Australia

Prevention of thrombosis in patients with polycythemia vera treated with hydroxyurea plus phlebotomies or hydroxyurea alone No ratings yet.

Alberto Alvarez-Larrán, MD
Department of Hematology
Hospital del Mar
Barcelona, Spain

Recent developments in the management of CML and their impact on Canadian clinical practice No ratings yet.

Pierre Laneuville, MD, FRCP
Associate Professor of Medicine and Oncology
McGill University Health Centre and Research Institute
Montreal, Quebec, Canada

The management of ITP and SAA in the era of TPO agonists No ratings yet.

Phillip Scheinberg, MD
Head, Clinical Hematology
Antônio Ermírio de Moraes Cancer Center
São José and Beneficência Portuguesa Hospital
São Paulo, Brazil

Recent evidence regarding the use of JAK inhibitors in the management of patients with MPNs No ratings yet.

Ruben A. Mesa, MD, FACP
Chair, Division of Hematology and Medical Oncology
Deputy Director, Mayo Clinic Cancer Center
Professor of Medicine
Mayo Clinic College of Medicine
Arizona, USA

Molecular markers in MPNs and their prognostic value No ratings yet.

Carlos Besses, MD, PhD
Department of Hematology
Hospital del Mar-IMIM
Barcelona, Spain

The emerging role of the TPO agonist eltrombopag in the treatment of thrombocytopenia in MDS and AML No ratings yet.

Jaroslav F. Prchal, MD, FRCPC
Chief, Department of Oncology
St. Mary's Hospital Center
Associate Professor
Department of Medicine and Oncology
McGill University
Montreal, Quebec, Canada

Treatment-free remission as a new goal in chronic myeloid leukemia No ratings yet.

Giuseppe Saglio, MD, PhD
Professor of Hematology
University of Turin
Ospedale Mauriziano-Torino
Turin, Italy